After-hours earnings delivered the day's biggest market moves. DocuSign rose sharply on a Q2 beat, with AI momentum credited for lifting results. UiPath also topped estimates and raised its revenue outlook. Both names reflect a broader theme: enterprise software companies are turning AI investment into real revenue.
Guidewire Software beat on Q4 EPS ($0.99 vs $0.94 est) and sales ($411M vs $402M est). But its Q1 guidance came in soft — $372-378M against a $387M estimate. The stock faces a mixed read.
Centrus Energy grabbed attention from a different angle. ORTEX data shows short interest utilization hitting 100% as of September 2. Zero shares remain available to borrow. With shorts fully maxed, any buying pressure has nowhere to go.
The broader chip narrative continues to run. Broadcom posted Q3 AI revenue up 221% but slid on guidance. Three analyst firms raised price targets — Rosenblatt and Cantor Fitzgerald both set $600. Bears remain thin on the ground with just 1.2% short interest.
Moderna took a hit as Rothschild downgraded to Sell with a $40 target — half the prior $81.
OpenAI launched Daybreak, a $1 billion program subsidising AI access for critical infrastructure defenders. The announcement ties back to Microsoft, which carries OpenAI's primary cloud partnership. MSFT remains the week's biggest dollar-volume options name.
California utilities stay under pressure. Wildfire liability concerns drove target cuts on PG&E, Sempra, and Edison International.
On the short side, Chewy remains the most-shorted large-cap name at 50.8% of free float. Adobe and Oracle report Thursday — the week's marquee earnings event.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
